Meeting
2022 ASCO Annual Meeting
Five- or 10-year colonoscopy for 1-2 non-advanced adenomatous polyps (FORTE) NRG-CC005 study: A randomized phase III non-inferiority trial comparing colorectal cancer incidence in participants with 1-2 non-advanced adenomas randomized to a 5- and 10-year surveillance colonoscopy exam schedule versus a 10-year surveillance colonoscopy exam schedule.
Authors
Robert E Schoen
University of Pittsburgh Medical Center, Pittsburgh, PA
Robert E Schoen , Hanna Bandos , Douglas Corley , Jeff Dueker , Greg Yothers , Jinbing Bai , Warner King Huh , Julie E. Bauman , Joan L. Walker , Deborah Bruner , Lisa A. Kachnic
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
NCT05080673
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS3631)
DOI
10.1200/JCO.2022.40.16_suppl.TPS3631
Abstract #
TPS3631
Poster Bd #
423b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Neoplasia detection via colonoscopic surveillance among young patients with MSH6 and PMS2-associated Lynch syndrome.
First Author: Alicia Latham
Poster
2021 Gastrointestinal Cancers Symposium
Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer.
First Author: Shai Friedland
Poster
2020 ASCO Virtual Scientific Program
Green tea extract to prevent colorectal adenomas in men and women: Results of the MIRACLE trial.
First Author: Thomas Jens Ettrich
Poster
2014 Gastrointestinal Cancers Symposium
Distribution and histopathology of colorectal polyps in the Asian population in the United States.
First Author: Samarth Patel